210 related articles for article (PubMed ID: 33707956)
1. Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma.
Huang H; Tan M; Zheng L; Yan G; Li K; Lu D; Cui X; He S; Lei D; Zhu B; Zhao J
Onco Targets Ther; 2021; 14():1737-1751. PubMed ID: 33707956
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma.
Yang H; Che D; Gu Y; Cao D
Front Genet; 2022; 13():940306. PubMed ID: 36110204
[No Abstract] [Full Text] [Related]
3. Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma.
Chen LH; Liu JF; Lu Y; He XY; Zhang C; Zhou HH
Front Oncol; 2021; 11():642144. PubMed ID: 34079754
[TBL] [Abstract][Full Text] [Related]
4. Construction of survival-related co-expression modules and identification of potential prognostic biomarkers of osteosarcoma using WGCNA.
Bian Y; Huang J; Zeng Z; Yao H; Tu J; Wang B; Zou Y; Xie X; Shen J
Ann Transl Med; 2022 Mar; 10(6):296. PubMed ID: 35434042
[TBL] [Abstract][Full Text] [Related]
5. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
6. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
Front Immunol; 2022; 13():992266. PubMed ID: 36405691
[TBL] [Abstract][Full Text] [Related]
7. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
8. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
9. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
12. Identification of
Jiang J; Ding Y; Wu M; Lyu X; Wang H; Chen Y; Wang H; Teng L
Front Oncol; 2020; 10():1765. PubMed ID: 33014868
[No Abstract] [Full Text] [Related]
13. Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.
Zou R; Zheng M; Tan M; Xu H; Luan N; Zhu L
Cancer Manag Res; 2020; 12():5057-5075. PubMed ID: 32617019
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
Front Oncol; 2021; 11():769727. PubMed ID: 34926275
[TBL] [Abstract][Full Text] [Related]
15. A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma.
Yang W; Wu H; Tong L; Wang Y; Guo Q; Xu L; Yan H; Yin C; Sun Z
Front Oncol; 2022; 12():1015094. PubMed ID: 36276092
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach.
Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY
Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy.
Niu J; Yan T; Guo W; Wang W; Zhao Z; Ren T; Huang Y; Zhang H; Yu Y; Liang X
Front Oncol; 2020; 10():1628. PubMed ID: 32974202
[TBL] [Abstract][Full Text] [Related]
19. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
20. Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma.
Chen D; Wan B; Cheng Y; Luo Y; Bai X; Guo J; Li G; Jin T; Nie J; Liu W; Wang R
PeerJ; 2023; 11():e15814. PubMed ID: 37663298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
